| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2872713 | The Annals of Thoracic Surgery | 2015 | 8 Pages |
Abstract
In this series of patients with clinical stage IIIa NSCLC treated with trimodality therapy, a higher dose of preoperative radiation therapy resulted in better response rates but that did not translate to better cancer-specific survival. Of significance, we observed a notably higher delayed noncancer mortality in the high-dose group.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Steven C. MD, Eric MD, Candice L. MD, Maurice MD, Brandi MD, Ralph W. MD, Alexander S. MD, Brian E. MD,